2024 Q2 Form 10-Q Financial Statement

#000166591824000101 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $9.709B $8.949B
YoY Change 13.66%
Cost Of Revenue $8.003B $7.454B
YoY Change 12.45%
Gross Profit $1.706B $1.495B
YoY Change 19.72%
Gross Profit Margin 17.57% 16.71%
Selling, General & Admin $1.354B $1.317B
YoY Change 9.37%
% of Gross Profit 79.37% 88.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $96.00M $105.0M
YoY Change -2.04%
% of Gross Profit 5.63% 7.02%
Operating Expenses $1.353B $1.330B
YoY Change 9.29%
Operating Profit $353.0M $165.0M
YoY Change 88.77%
Interest Expense -$81.00M $79.00M
YoY Change -200.0%
% of Operating Profit -22.95% 47.88%
Other Income/Expense, Net -$3.000M $1.000M
YoY Change -400.0%
Pretax Income $269.0M $87.00M
YoY Change 151.4%
Income Tax $71.00M $5.000M
% Of Pretax Income 26.39% 5.75%
Net Earnings $198.0M $82.00M
YoY Change 141.46%
Net Earnings / Revenue 2.04% 0.92%
Basic Earnings Per Share $0.81 $0.33
Diluted Earnings Per Share $0.80 $0.33
COMMON SHARES
Basic Shares Outstanding 245.9M shares 244.9M shares
Diluted Shares Outstanding 248.0M shares 248.0M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $405.0M $267.0M
YoY Change 38.7%
Cash & Equivalents $405.0M $267.0M
Short-Term Investments
Other Short-Term Assets $17.00M $19.00M
YoY Change -26.09%
Inventory $1.593B $1.620B
Prepaid Expenses $131.0M $152.0M
Receivables $2.000B $2.000B
Other Receivables $212.0M $210.0M
Total Short-Term Assets $4.334B $4.234B
YoY Change 5.86%
LONG-TERM ASSETS
Property, Plant & Equipment $2.359B $2.303B
YoY Change 8.61%
Goodwill $5.779B $5.697B
YoY Change 2.74%
Intangibles $867.0M $796.0M
YoY Change 12.02%
Long-Term Investments
YoY Change
Other Assets $364.0M $360.0M
YoY Change -2.41%
Total Long-Term Assets $9.369B $9.156B
YoY Change 4.75%
TOTAL ASSETS
Total Short-Term Assets $4.334B $4.234B
Total Long-Term Assets $9.369B $9.156B
Total Assets $13.70B $13.39B
YoY Change 5.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.349B $2.273B
YoY Change 10.07%
Accrued Expenses $706.0M $651.0M
YoY Change 17.28%
Deferred Revenue
YoY Change
Short-Term Debt $193.0M $198.0M
YoY Change -3.02%
Long-Term Debt Due $118.0M $116.0M
YoY Change 0.85%
Total Short-Term Liabilities $3.366B $3.238B
YoY Change 10.29%
LONG-TERM LIABILITIES
Long-Term Debt $4.589B $4.585B
YoY Change -2.22%
Other Long-Term Liabilities $455.0M $442.0M
YoY Change 3.88%
Total Long-Term Liabilities $455.0M $442.0M
YoY Change 3.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.366B $3.238B
Total Long-Term Liabilities $455.0M $442.0M
Total Liabilities $8.692B $8.565B
YoY Change 2.43%
SHAREHOLDERS EQUITY
Retained Earnings $1.789B $1.591B
YoY Change 64.88%
Common Stock $3.699B $3.671B
YoY Change 15.09%
Preferred Stock
YoY Change
Treasury Stock (at cost) $365.0M $324.0M
YoY Change 660.42%
Treasury Stock Shares
Shareholders Equity $5.011B $4.825B
YoY Change
Total Liabilities & Shareholders Equity $13.70B $13.39B
YoY Change 5.1%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $198.0M $82.00M
YoY Change 141.46%
Depreciation, Depletion And Amortization $96.00M $105.0M
YoY Change -2.04%
Cash From Operating Activities $482.0M $139.0M
YoY Change 72.76%
INVESTING ACTIVITIES
Capital Expenditures $69.00M $87.00M
YoY Change 13.11%
Acquisitions
YoY Change
Other Investing Activities -$213.0M $1.000M
YoY Change -21400.0%
Cash From Investing Activities -$282.0M -$86.00M
YoY Change 370.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -62.00M -$55.00M
YoY Change -55.07%
NET CHANGE
Cash From Operating Activities 482.0M $139.0M
Cash From Investing Activities -282.0M -$86.00M
Cash From Financing Activities -62.00M -$55.00M
Net Change In Cash 138.0M -$2.000M
YoY Change 70.37%
FREE CASH FLOW
Cash From Operating Activities $482.0M $139.0M
Capital Expenditures $69.00M $87.00M
Free Cash Flow $413.0M $52.00M
YoY Change 89.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-2000000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7454000000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7117000000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
1495000000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
1425000000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1317000000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1238000000 usd
CY2024Q1 us-gaap Restructuring Costs
RestructuringCosts
13000000 usd
CY2023Q2 us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1330000000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1238000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
165000000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1000000 usd
CY2024Q1 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
3000000 usd
CY2023Q2 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
7000000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5000000 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
187000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
79000000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
81000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
87000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
107000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
82000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
82000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-2000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
84000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
83000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
82000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
82000000 usd
CY2024Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 usd
CY2023Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
7000000 usd
CY2024Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
82000000 usd
CY2023Q2 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
75000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
245000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
226000000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
248000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
252000000 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4749000000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
20000000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
13000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4825000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3961000000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
11000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
161000000 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
7000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1000000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
34000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
82000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4179000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
82000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
82000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
105000000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
98000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
15000000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
14000000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7000000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
173000000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
197000000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20000000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9000000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1000000 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2000000 usd
CY2024Q1 usfd Increase Decrease In Accounts Payable And Bank Checks Outstanding
IncreaseDecreaseInAccountsPayableAndBankChecksOutstanding
221000000 usd
CY2023Q2 usfd Increase Decrease In Accounts Payable And Bank Checks Outstanding
IncreaseDecreaseInAccountsPayableAndBankChecksOutstanding
321000000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-105000000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-53000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
139000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
279000000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87000000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
61000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-86000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
457000000 usd
CY2023Q2 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
111000000 usd
CY2024Q1 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
14000000 usd
CY2023Q2 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
14000000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2024Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
426000000 usd
CY2023Q2 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
13000000 usd
CY2024Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 usd
CY2023Q2 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
7000000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
13000000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
34000000 usd
CY2024Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1000000 usd
CY2023Q2 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
5000000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
5000000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7000000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
20000000 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-55000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-138000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
81000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
269000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
211000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
267000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
292000000 usd
CY2024Q1 us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
0 usd
CY2023Q2 us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
162000000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
93000000 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
61000000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5000000 usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3000000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20000000 usd
CY2023Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17000000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
56000000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
47000000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7000000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9000000 usd
CY2024Q1 us-gaap Stock Issued1
StockIssued1
4000000 usd
CY2023Q2 us-gaap Stock Issued1
StockIssued1
1000000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2000000000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1900000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8949000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8542000000 usd
CY2024Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
533000000 usd
CY2023Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
488000000 usd
CY2024Q1 usfd Increase Decrease In Cost Of Goods Sold Due To Change In Inventory Lifo Reserve
IncreaseDecreaseInCostOfGoodsSoldDueToChangeInInventoryLIFOReserve
45000000 usd
CY2023Q2 usfd Increase Decrease In Cost Of Goods Sold Due To Change In Inventory Lifo Reserve
IncreaseDecreaseInCostOfGoodsSoldDueToChangeInInventoryLIFOReserve
20000000 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2023Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 usd
CY2024Q1 usfd Allowance For Doubtful Vendor Receivables Current
AllowanceForDoubtfulVendorReceivablesCurrent
6000000 usd
CY2023Q4 usfd Allowance For Doubtful Vendor Receivables Current
AllowanceForDoubtfulVendorReceivablesCurrent
5000000 usd
CY2023Q2 usfd Allowance For Doubtful Vendor Receivables Current
AllowanceForDoubtfulVendorReceivablesCurrent
8000000 usd
CY2022Q4 usfd Allowance For Doubtful Vendor Receivables Current
AllowanceForDoubtfulVendorReceivablesCurrent
8000000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3224000000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3219000000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
93000000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
87000000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12000000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
5697000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
5697000000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
796000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
803000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
109000000 usd
CY2024Q1 us-gaap Interest Rate Fair Value Hedge Derivative At Fair Value Net
InterestRateFairValueHedgeDerivativeAtFairValueNet
1000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
208000000 usd
CY2023Q4 us-gaap Interest Rate Fair Value Hedge Derivative At Fair Value Net
InterestRateFairValueHedgeDerivativeAtFairValueNet
1000000 usd
CY2024Q1 us-gaap Derivative Number Of Instruments Held
DerivativeNumberOfInstrumentsHeld
2 derivative
CY2024Q1 us-gaap Derivative Term Of Contract
DerivativeTermOfContract
P2Y
CY2024Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
450000000 usd
CY2024Q1 us-gaap Long Term Debt Percentage Bearing Variable Interest Rate
LongTermDebtPercentageBearingVariableInterestRate
0.24
CY2024Q1 us-gaap Derivative Cap Interest Rate
DerivativeCapInterestRate
0.05
CY2024Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
1000000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
4701000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
4674000000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
116000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
110000000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4585000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4564000000 usd
CY2024Q1 usfd Debt Instrument Percentage Of Principal Amount At Floating Rate
DebtInstrumentPercentageOfPrincipalAmountAtFloatingRate
0.30
CY2024Q1 us-gaap Derivative Cap Interest Rate
DerivativeCapInterestRate
0.05
CY2024Q1 usfd Debt Covenants Restricted Payment Capacity
DebtCovenantsRestrictedPaymentCapacity
2000000000 usd
CY2024Q1 usfd Restricted Assets
RestrictedAssets
2800000000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
13000000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
15000000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
7000000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
7000000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
13000000 usd
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
5000000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
15000000 usd
CY2024Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
0 usd
CY2023Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
0 usd
CY2024Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
5000000 usd
CY2023Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
10000000 usd
CY2024Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
5000000 usd
CY2023Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
12000000 usd
CY2024Q1 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-2000000 usd
CY2023Q2 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-1000000 usd
CY2024Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
2000000 usd
CY2023Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-1000000 usd
CY2024Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
21000000 usd
CY2023Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
17000000 usd
CY2024Q1 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
15000000 usd
CY2023Q2 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
13000000 usd
CY2024Q1 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
15000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-6000000 usd
CY2024Q1 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
3000000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.23
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-4000000 usd
CY2024Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
1800000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
82000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
82000000 usd
CY2024Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 usd
CY2023Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
7000000 usd
CY2024Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
82000000 usd
CY2023Q2 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
75000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
245000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
226000000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
23000000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
248000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
252000000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2022Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
283988 shares
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
13000000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
179000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.06
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q1 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
693000000 usd
CY2024Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
946000000 usd
CY2024Q1 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
158000000 usd
CY2024Q1 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
0 usd
CY2024Q1 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
0 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001665918-24-000101-index-headers.html Edgar Link pending
0001665918-24-000101-index.html Edgar Link pending
0001665918-24-000101.txt Edgar Link pending
0001665918-24-000101-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usfd-20240330.htm Edgar Link pending
usfd-20240330.xsd Edgar Link pending
usfd-20240330_g1.jpg Edgar Link pending
usfd3302024ex102.htm Edgar Link pending
usfd3302024ex103.htm Edgar Link pending
usfd3302024ex311.htm Edgar Link pending
usfd3302024ex312.htm Edgar Link pending
usfd3302024ex321.htm Edgar Link pending
usfd3302024ex322.htm Edgar Link pending
usfd-20240330_def.xml Edgar Link unprocessable
usfd-20240330_lab.xml Edgar Link unprocessable
usfd-20240330_pre.xml Edgar Link unprocessable
usfd-20240330_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
usfd-20240330_cal.xml Edgar Link unprocessable